BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25156627)

  • 21. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
    Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
    Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression.
    Klampfer L; Huang J; Corner G; Mariadason J; Arango D; Sasazuki T; Shirasawa S; Augenlicht L
    J Biol Chem; 2003 Nov; 278(47):46278-87. PubMed ID: 12972432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.
    Van Winkle JA; Constant DA; Li L; Nice TJ
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.
    Kraus TA; Lau JF; Parisien JP; Horvath CM
    J Biol Chem; 2003 Apr; 278(15):13033-8. PubMed ID: 12574168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
    Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
    J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
    Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
    Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
    Paulus C; Krauss S; Nevels M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Measles Virus V Protein Binding Site to STAT2 Overlaps That of IRF9.
    Nagano Y; Sugiyama A; Kimoto M; Wakahara T; Noguchi Y; Jiang X; Saijo S; Shimizu N; Yabuno N; Yao M; Gooley PR; Moseley GW; Tadokoro T; Maenaka K; Ose T
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular localization and functional characterization of a fish IRF9 from crucian carp Carassius auratus.
    Shi J; Zhang YB; Liu TK; Sun F; Gui JF
    Fish Shellfish Immunol; 2012 Aug; 33(2):258-66. PubMed ID: 22626811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1.
    Lou YJ; Pan XR; Jia PM; Li D; Xiao S; Zhang ZL; Chen SJ; Chen Z; Tong JH
    Cancer Res; 2009 Apr; 69(8):3673-80. PubMed ID: 19351818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
    Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
    J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.
    Rauch I; Rosebrock F; Hainzl E; Heider S; Majoros A; Wienerroither S; Strobl B; Stockinger S; Kenner L; Müller M; Decker T
    Mol Cell Biol; 2015 Jul; 35(13):2332-43. PubMed ID: 25918247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
    Cheon H; Holvey-Bates EG; Schoggins JW; Forster S; Hertzog P; Imanaka N; Rice CM; Jackson MW; Junk DJ; Stark GR
    EMBO J; 2013 Oct; 32(20):2751-63. PubMed ID: 24065129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling.
    Maiwald T; Schneider A; Busch H; Sahle S; Gretz N; Weiss TS; Kummer U; Klingmüller U
    FEBS J; 2010 Nov; 277(22):4741-54. PubMed ID: 20964804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional annotation of IFN-alpha-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines.
    Holko M; Williams BR
    J Interferon Cytokine Res; 2006 Aug; 26(8):534-47. PubMed ID: 16881864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon Regulatory Factor 9 Structure and Regulation.
    Paul A; Tang TH; Ng SK
    Front Immunol; 2018; 9():1831. PubMed ID: 30147694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.
    Blaszczyk K; Nowicka H; Kostyrko K; Antonczyk A; Wesoly J; Bluyssen HA
    Cytokine Growth Factor Rev; 2016 Jun; 29():71-81. PubMed ID: 27053489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.
    Tsuno T; Mejido J; Zhao T; Schmeisser H; Morrow A; Zoon KC
    J Immunother; 2009 Oct; 32(8):803-16. PubMed ID: 19752753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRF9 and unphosphorylated STAT2 cooperate with NF-κB to drive IL6 expression.
    Nan J; Wang Y; Yang J; Stark GR
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3906-3911. PubMed ID: 29581268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine Reproductive and Respiratory Syndrome Virus nsp11 Antagonizes Type I Interferon Signaling by Targeting IRF9.
    Wang D; Chen J; Yu C; Zhu X; Xu S; Fang L; Xiao S
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.